“Palbociclib plus endocrine therapy in Premenopausal women in HR+/Her2- Breast Cancer with Visceral Metastases versus Combined Chemotherapy”, JOC, vol. 24, no. 3, pp. 635–642, Sep. 2025, doi: 10.64149/J.Carcinog.24.3.635-642.